16.8 C
New York
Saturday, June 10, 2023

Study: Inoculated yet Covid-19 positive people at few danger.

- Advertisement -
- Advertisement -
- Advertisement -

The study was accomplished  on 200 transited  people who had taken the first dose of Oxford-AstraZeneca vaccine produced by the Serum Institute of India A study has found people who were coronavirus transited after inoculation  are at fewer health danger .

The study was guided from February 7 to April 13 on 200 such cases by a team of researchist in University of Chittagong Veterinary and Animal Sciences (CVASU).The study by CVASU found that only one transited patient passin away after taking the first dose of the vaccine.According to the study, 82.5% of the inoculated yet transited  patients did not have to go to hospital for treatment. Although 17.5% of them were admitted to the hospital, no significant health danger  was observed between  them.

- Advertisement -

More than 88% of 200 transited  people did not have respiratory problems and 92% of the patients did not need oxygen. The study showed that most of the inoculated people became transited on average 32 days after inoculation and their average body temperature was 101 degrees.These findings came up in the study in Chittagong region, led by Vice Chancellor Prof Gautam Buddha Das of CVASU, on the health dangers of coronavirus undergoes.

The study was performed on 200 transited  people who had taken the first dose of Oxford-AstraZeneca vaccine produced by the Serum Institute of India.Prof Dr Sharmin Chowdhury, Dr Iftekhar Ahmed Rana, Dr Trideep Das, Dr Pranesh Dutta, Dr Sirajul Islam and Dr Tanvir Ahmad Nizami were between  others in the research team. Only 35 of the 200 had to be hospitalized for treatment and peace  of them took treatment from home.

- Advertisement -

Related Articles

Leave a Comment:

Stay Connected

22,025FansLike
3,802FollowersFollow
18,600SubscribersSubscribe
- Advertisement -

Latest Articles

Adblock Detected

Please consider supporting us by disabling your ad blocker

Refresh Page

Page 1

You are visiting this page for the 1st time.

Page: 1